Literature DB >> 23791890

Incremental value of magnetic resonance imaging for clinically high risk prostate cancer in 922 radical prostatectomies.

In Gab Jeong1, Ju Hyun Lim, Dalsan You, Mi-Hyun Kim, Hyuk Jae Choi, Jeong Kon Kim, Kyoung-Sik Cho, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim.   

Abstract

PURPOSE: We investigated the incremental value of magnetic resonance imaging in addition to clinical variables for predicting pathological outcomes and disease recurrence in patients with clinically high risk prostate cancer.
MATERIALS AND METHODS: A total of 922 consecutive patients with clinically high risk prostate cancer underwent magnetic resonance imaging before radical prostatectomy. We created multivariate logistic regression and Cox proportional hazards models with clinical variables only or combined with magnetic resonance imaging data to predict pathological outcomes and biochemical recurrence. The models were compared using ROC curves and the Harrell concordance index.
RESULTS: The proportion of patients with pathological extracapsular extension, seminal vesicle invasion and lymph node metastasis was 57.5%, 12.7% and 6.3%, respectively. The sensitivity and specificity of extracapsular extension, seminal vesicle invasion and lymph node metastasis detection were 43% and 84.2%, 34.9% and 93.8%, and 14.0% and 96.9%, respectively. The area under the ROC curve of the model with clinical variable and magnetic resonance imaging data was greater than that of the model with clinical variables alone to predict extracapsular extension and seminal vesicle invasion (0.734 vs 0.697, p=0.001 and 0.750 vs 0.698, p<0.001, respectively). The 5-year biochemical recurrence-free survival rate was 56.1%. To predict biochemical recurrence the concordance index of the multivariate model with clinical variables only and with clinical variables plus magnetic resonance imaging data was 0.563 and 0.599, respectively (p=0.003).
CONCLUSIONS: Magnetic resonance imaging findings have incremental value in addition to clinical variables for predicting pathological outcomes and disease recurrence.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AUC; BCR; DW; ECE; MR; PSA; RP; SVI; area under ROC curve; biochemical recurrence; c-index; concordance index; diffusion-weighted; extracapsular extension; magnetic resonance; magnetic resonance imaging; prognosis; prostate; prostate specific antigen; prostatectomy; prostatic neoplasms; radical prostatectomy; seminal vesicle invasion

Mesh:

Year:  2013        PMID: 23791890     DOI: 10.1016/j.juro.2013.06.035

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

1.  Accuracy of preoperative multiparametric magnetic resonance imaging for prediction of unfavorable pathology in patients with localized prostate cancer undergoing radical prostatectomy.

Authors:  Hakmin Lee; Chan Kyo Kim; Byung Kwan Park; Hyun Hwan Sung; Deok Hyun Han; Hwang Gyun Jeon; Byong Chang Jeong; Seong Il Seo; Seong Soo Jeon; Han Yong Choi; Hyun Moo Lee
Journal:  World J Urol       Date:  2016-10-13       Impact factor: 4.226

Review 2.  Optimizing Patient Population for MP-MRI and Fusion Biopsy for Prostate Cancer Detection.

Authors:  Thomas P Frye; Peter A Pinto; Arvin K George
Journal:  Curr Urol Rep       Date:  2015-07       Impact factor: 3.092

3.  Multiparametric magnetic resonance imaging for pre-treatment local staging of prostate cancer: A Cancer Care Ontario clinical practice guideline.

Authors:  Jennifer Salerno; Antonio Finelli; Chris Morash; Scott C Morgan; Nicholas Power; Nichola Schieda; Masoom A Haider
Journal:  Can Urol Assoc J       Date:  2016-10-13       Impact factor: 1.862

4.  Role of multiparametric magnetic resonance imaging in the diagnosis of prostate cancer.

Authors:  Soroush Rais-Bahrami; Baris Turkbey; Kinzya B Grant; Peter A Pinto; Peter L Choyke
Journal:  Curr Urol Rep       Date:  2014-03       Impact factor: 3.092

5.  Multiparametric magnetic resonance imaging and image-guided biopsy to detect seminal vesicle invasion by prostate cancer.

Authors:  Dima Raskolnikov; Arvin K George; Soroush Rais-Bahrami; Baris Turkbey; Nabeel A Shakir; Chinonyerem Okoro; Jason T Rothwax; Annerleim Walton-Diaz; M Minhaj Siddiqui; Daniel Su; Lambros Stamatakis; Maria J Merino; Bradford J Wood; Peter L Choyke; Peter A Pinto
Journal:  J Endourol       Date:  2014-10-14       Impact factor: 2.942

Review 6.  Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists.

Authors:  Sangjun Yoo; Jeong Kon Kim; In Gab Jeong
Journal:  Korean J Urol       Date:  2015-06-30

Review 7.  Multiparametric MRI for localized prostate cancer: lesion detection and staging.

Authors:  Daniel J A Margolis
Journal:  Biomed Res Int       Date:  2014-11-30       Impact factor: 3.411

Review 8.  Diagnosis of prostate cancer via nanotechnological approach.

Authors:  Benedict J Kang; Minhong Jeun; Gun Hyuk Jang; Sang Hoon Song; In Gab Jeong; Choung-Soo Kim; Peter C Searson; Kwan Hyi Lee
Journal:  Int J Nanomedicine       Date:  2015-10-19

9.  The long-term outcomes of radical prostatectomy for very high-risk prostate cancer pT3b-T4 N0-1 on definitive histopathology.

Authors:  Jan Kliment; Boris Elias; Katarina Baluchova; Jan Kliment
Journal:  Cent European J Urol       Date:  2017-01-03

10.  Diagnostic accuracy of multiparametric magnetic resonance imaging in detecting extracapsular extension in intermediate and high - risk prostate cancer.

Authors:  Cristina Dominguez; Mauricio Plata; Juan Guillermo Cataño; Mauricio Palau; Diego Aguirre; Jorge Narvaez; Stephanie Trujillo; Felipe Gómez; Carlos Gustavo Trujillo; Juan Ignacio Caicedo; Camilo Medina
Journal:  Int Braz J Urol       Date:  2018 Jul-Aug       Impact factor: 1.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.